López-Ortega María-Elena, Santiago-Luna E, Salazar-Páramo M, Montañez-Fernández JL, Osuna-Rubio J, González-Ojeda A

Language: Spanish
References: 31
Page: 337-341
PDF size: 62.58 Kb.

ABSTRACT

Background: Head-out water immersion has been proposed as an adjuvant treatment in refractory ascites and hepatorenal syndrome. We undertook this study to present the results of management of patients with refractory ascites.
Methods: We included 10 patients with diagnosis of hepatic cirrhosis and refractory ascites. Variables were measured in four stages: stage I (basal); II (at the end of water immersion); III (72 h after water immersion); IV (1 week after water immersion concludes). Clinical and laboratory variables were measured and included general exams and renal function tests. Friedman test was used for statistics to establish differences between variables at the end of stage IV. We considered statistical significance when p ‹0.05.
Results: Median age was 53.8 years, corresponding to seven men and three women with a Child’s classification of B or C. Statistically significant variables were weight (p = 0.02) and abdominal circumference (p = 0.003), as a result of an increased urine output (p = 0.03) and glomerular filtration rate (p ‹0.002). Renal plasma flow increased until stage III, returning to basal level in stage IV. Serum potassium levels decreased but the difference was marginal (p = 0.052). During follow-up, two patients died as a consequence of liver insufficiency.
Conclusions: Head-out water immersion showed a decrease in weight and abdominal circumference, which means reduction of ascites. There was a transitory improvement in renal function. No collateral events were reported. Water immersion could be proposed as an adjuvant treatment in patients with refractory ascites and liver cirrhosis.

REFERENCES

1. 1. Gentilini P, Laffi G, La Villa G, Romanelli RG, Blendis LM. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? J Hepatol 1999;31(6):1088-1097.

2. 2. Wong F, Liu P, Blendis L. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis. Gut 2001;49(6):847-851.

3. 3. Runyon B. Ascitis y peritonitis bacteriana espontánea. En: Fordtran S, ed. Enfermedades gastrointestinales y hepáticas. 6ª edición. México: Médica Panamericana; 2000. pp. 1420-1425.

4. 4. Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Hepatology 1993;18(3):519-528.

5. 5. Fernández-Esparrach G, Sánchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34(1):46-52.

6. 6. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23(1):164-176.

7. 7. Bataller R, Gines P, Arroyo V, Rodes J. Hepatorenal syndrome. Clin Liver Dis 2000;4(2):487-507.

8. 8. McCormick PA. Improving prognosis in hepatorenal syndrome. Gut 2000; 47(2):166,167.

9. 9. Gerbes AL, Vollmar AM. Water immersion increases the concentration of the immunoreactive N-terminal fragment of proatrial natriuretic factor in human plasma. Bioch Biophys Res Commun 1988;156(1):228-232.

10. Gerbes AL, Wernze H, Arendt RM, Riedel A, Sauerbruch T, Paumgartner G. Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis. Hepatology 1989; 9(3):417-422.

11. Yersin B, Burnier M, Magnenat P. Improvement of renal failure with repeated head-out water immersions in patients with hepatorenal syndrome associated with alcoholic hepatitis. Am J Nephrol 1995;15(3):260-265.

12. Skorecki KL, Leung WM, Campbell P, Warner LC, Wong PY, Bull S, et al. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects. Am J Med 1988; 85(3):375-382.

13. Gerbes AL, Pilz A, Wernze H, Jungst D. Renal sodium handling and neurohumoral systems in patients with cirrhosis in sitting posture: effects of spironolactone and water immersion. Clin Invest 1993;71(11):894-897.

14. Bichet DG, Groves BM, Schrier RW. Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients. Kidney Intern 1983;24(6):788-794.

15. Epstein M, Loutzenhiser R, Friedland E, Aceto RM, Camargo MJ, Atlas SA. Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans. J Clin Invest 1987;79(3):738-745.

16. Vesely DL, Preston R, Gower WR Jr, Chiou S, Epstein M. Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans. Am J Nephrol 1996;16(2):128-137.

17. Nicholls KM, Shapiro MD, Groves BS, Schrier RW. Factors determining renal response to water immersion in non-excretor cirrhotic patients. Kidney Int 1986; 30(3):417-421.

18. Dijkhorst-Oei LT, Boer P, Rabelink TJ, Koomans HA. Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans. J Am Soc Nephrol 2000;11(7):1293-1302.

19. Miwa C, Sugiyama Y, Mano T, Iwase S, Matsukawa T. Sympatho-vagal responses in humans to thermoneutral head-out water immersion. Aviat Space Environ Med 1997;68(12):1109-1114.

20. Epstein M, Loutzenhiser RD, Friedland E, Aceto RM, Camargo MJ, Atlas SA. Increases in circulating atrial natriuretic factor during immersion-induced central hypervolaemia in normal humans. J Hypertension Suppl 1986; 4(2):S93-S99.

21. Buemi M, Corica F, Di Pasquale G, Aloisi C, Sofi M, Casuscelli T, et al. Water immersion increases urinary excretion of aquaporin-2 in healthy humans. Nephron 2000;85(1):20-26.

22. Pendergast DR, de Bold AJ, Pazik M, Hong SK. Effect of head-out immersion on plasma atrial natriuretic factor in man. Proc Soc Exp Biol Med 1987;184(4):429-435.

23. Kurabayashi H, Tamura K, Tamura J, Kubota K. The effects of hydraulic pressure on atrial natriuretic peptide during rehabilitative head-out water immersion. Life Sci 2001;69(9):1017-1021.

24. Ogihara T, Shima J, Hara H, Tabuchi Y, Hashizume K, Nagano M, et al. Significant increase in plasma immunoreactive atrial natriuretic polypeptide concentration during head-out water immersion. Life Sci 1986; 38(26):2413-2418.

25. Miki K, Shiraki K, Sagawa S, de Bold AJ, Hong SK. Atrial natriuretic factor during head-out immersion at night. Am J Physiol 1988; 254(2 Pt 2):R235-R241.

26. Vesely DL, Preston R, Winters CJ, Rico DM, Sallman AL, Epstein M. Increased release of the N-terminal and C-terminal portions of the atrial natriuretic factor prohormone during immersion-induced central hypervolemia in cirrhotic humans. Am J Nephrol 1991;11(3):207-216.

27. Muc M, Nowakowska E. Therapeutic use of the method of water immersion in a patient with ascites in uncompensated cirrhosis of the liver. Pol Arch Med Wewn 1992;87(1):68-74.

28. Ponce P, Moreira P. Water immersion in an anuric cirrhotic patient. Nephron 1986;43(2):144-147.

29. Sramek P, Simeckova M, Jansky L, Savlikova J, Vybiral S. Human physiological responses to immersion into water of different temperatures. Europ J Appl Physiol 2000;81(5):436-442.

30. Yamazaki F, Endo Y, Torii R, Sagawa S, Shiraki K. Continuous monitoring of change in hemodilution during water immersion in humans: effect of water temperature. Aviat Space Environ Med 2000;71(6):632-639.

31. Shiraki K, Konda N, Sagawa S, Claybaugh JR, Hong SK. Cardiorenal-endocrine responses to head-out immersion at night. J Appl Physiol 1986;60(1):176-183.